Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000711290 | SCV000113813 | uncertain significance | not provided | 2014-12-20 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000081878 | SCV000597873 | uncertain significance | not specified | 2016-06-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001082583 | SCV000755435 | likely benign | Cohen syndrome | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000711290 | SCV000841627 | uncertain significance | not provided | 2017-10-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000623758 | SCV000848156 | uncertain significance | Inborn genetic diseases | 2018-01-30 | criteria provided, single submitter | clinical testing | The p.Q416H variant (also known as c.1248G>T), located in coding exon 8 of the VPS13B gene, results from a G to T substitution at nucleotide position 1248. The glutamine at codon 416 is replaced by histidine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Illumina Laboratory Services, |
RCV001082583 | SCV001323817 | uncertain significance | Cohen syndrome | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Center for Genomics, |
RCV001082583 | SCV001468402 | uncertain significance | Cohen syndrome | 2021-03-30 | criteria provided, single submitter | clinical testing | VPS13B NM_152564.4 exon 9 p.Gln416His (c.1248G>T): This variant has not been reported in the literature but is present in 0.4% (45/10348) of Ashkenazi Jewish alleles in the Genome Aggregation Database https://gnomad.broadinstitute.org/variant/8-100146901-G-T). This variant is present in ClinVar (Variation ID:95831). Evolutionary conservation and computational predictive tools suggest that this variant may impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Laboratoire de Génétique Moléculaire, |
RCV000711290 | SCV001468935 | likely benign | not provided | 2023-12-05 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001082583 | SCV001529777 | uncertain significance | Cohen syndrome | 2018-03-20 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Genome- |
RCV001082583 | SCV001653322 | uncertain significance | Cohen syndrome | 2021-05-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000711290 | SCV001770313 | uncertain significance | not provided | 2020-04-21 | criteria provided, single submitter | clinical testing | Identified as heterozygous via exome sequencing in a sibling of an individual with autism (Yu et al., 2013); Identified as heterozgyous via exome sequencing for carrier screening for autosomal recessive conditions in a healthy individual (Mehrjoo et al., 2015); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 26443248, 23352163) |
Institute for Clinical Genetics, |
RCV000711290 | SCV002011570 | uncertain significance | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
New York Genome Center | RCV001082583 | SCV003925082 | uncertain significance | Cohen syndrome | 2022-04-11 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003935062 | SCV004747452 | likely benign | VPS13B-related disorder | 2021-09-02 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |